June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Epidemiology of retinopathy in African Americans with impaired fasting glucose and type 2 diabetes in the Jackson Heart Study
Author Affiliations & Notes
  • Lucia Sobrin
    Retina/Uveitis, Harvard Med Mass Eye & Ear Infirmary, Boston, MA
  • Alan Penman
    Medicine, University of Mississippi Medical Center, Jackson, MS
    Biostatistics, University of Mississippi Medical Center, Jackson, MS
  • Suzanne Hoadley
    Ophthalmology, University of Mississippi Medical Center, Jackson, MS
  • James Wilson
    Medicine, University of Mississippi Medical Center, Jackson, MS
  • Herman Taylor
    Medicine, University of Mississippi Medical Center, Jackson, MS
  • Ching Chen
    Ophthalmology, University of Mississippi Medical Center, Jackson, MS
  • Footnotes
    Commercial Relationships Lucia Sobrin, None; Alan Penman, None; Suzanne Hoadley, None; James Wilson, None; Herman Taylor, None; Ching Chen, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2171. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Lucia Sobrin, Alan Penman, Suzanne Hoadley, James Wilson, Herman Taylor, Ching Chen; Epidemiology of retinopathy in African Americans with impaired fasting glucose and type 2 diabetes in the Jackson Heart Study. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2171.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the prevalence and risk factors for retinopathy in a population-based study of African Americans (AA) with impaired fasting glucose (IFG) and type 2 diabetes (T2D).

Methods: Participants with IFG and T2D in the Jackson Heart Study (JHS) were invited to participate in an ancillary study of retinopathy. Dilated, bilateral, digital, seven-field fundus photography was obtained in each participant. The photographs were scored by two masked readers using the Early Treatment Diabetic Retinopathy (ETDRS) adaptation of the modified Airlie House classification. Risk factor measurements including duration of diabetes, hemoglobin A1C (HbA1C), blood pressure, body mass index (BMI) and lipid levels were obtained from each participant’s most recent JHS visit. Grade of retinopathy was defined as the higher grade of the two eyes. Logistic regression (SAS 9.3, SAS Institute Inc., Cary, NC) was used to estimate the association between presence of any retinopathy (ETDRS grade ≥ 14) and traditional risk factors.

Results: Three hundred and eighty-four participants with IFG and 515 participants with T2D were enrolled in this ancillary study of retinopathy. The prevalence of any retinopathy among participants with IFG was 9.8%. The overall prevalence rates of any retinopathy and proliferative retinopathy were 37.3% and 5.5%, respectively, in the participants with T2D. Among those with IFG, presence of retinopathy was associated with a higher BMI (35.2 kg/m2 vs. 31.4 kg/m2, p=0.03). Among those with T2D, presence of retinopathy was associated with a higher HbA1C level (6.8% vs. 6.2%, p=0.002) and longer duration of diabetes (16.5 years vs. 8.9 years, p<0.0001). Overall, the odds of having any retinopathy were 1.63 (95% confidence interval: 1.08, 2.47) higher in participants with HbA1C ≥ 6.5% compared with those with a HbA1C < 6.5%. No other statistically significant associations with other traditional risk factors were identified.

Conclusions: The prevalence rates of any retinopathy in AA with IFG and T2D in the JHS are similar to those in other populations. Among participants with IFG, higher BMI is a modifiable risk factor for retinopathy that deserves further investigation. Duration of diabetes and HbA1C level, the two most strongly associated retinopathy risk factors in other ethnicities, were also associated with retinopathy in JHS participants with T2D.

Keywords: 499 diabetic retinopathy • 463 clinical (human) or epidemiologic studies: prevalence/incidence • 464 clinical (human) or epidemiologic studies: risk factor assessment  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×